We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
(+2.3%)
Cap. Flow
-$59.5M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$40.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$30.9M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$26.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17M |
| 5 |
Amazon
AMZN
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$68.4M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$29.2M |
| 3 |
Apple
AAPL
|
+$23.6M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$20.5M |
| 5 |
VAL
Valspar
VAL
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.4% |
| 2 | Technology | 15.29% |
| 3 | Healthcare | 13.69% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPXL
1451
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.46M | 0.01% |
152,717
+7,393
| +5% | +$109K |
|
|
ICPT
1452
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.45M | 0.01% |
20,244
+713
| +4% | +$82.6K |
|
1453
Prothena Corp
PRTA
$448M
| $2.45M | 0.01% |
45,262
+2,936
| +7% | +$156K |
|
1454
Gibraltar Industries
ROCK
$1.28B
| $2.44M | 0.01% |
68,566
+2,182
| +3% | +$77K |
|
1455
HEICO Corp
HEI
$49.6B
| $2.44M | 0.01% |
66,391
+270
| +0.4% | +$9.94K |
|
|
NTUS
1456
DELISTED
Natus Medical Inc
NTUS
| $2.44M | 0.01% |
65,445
-542
| -0.8% | -$19.6K |
|
|
NAVG
1457
DELISTED
Navigators Group Inc
NAVG
| $2.43M | 0.01% |
44,267
-2,044
| -4% | -$109K |
|
|
HF
1458
DELISTED
HFF Inc.
HF
| $2.42M | 0.01% |
69,754
+403
| +0.6% | +$12.4K |
|
|
VSTO
1459
DELISTED
Vista Outdoor Inc.
VSTO
| $2.42M | 0.01% |
107,525
+2,958
| +3% | +$62.4K |
|
1460
Qualys
QLYS
$4.76B
| $2.42M | 0.01% |
59,273
+4,968
| +9% | +$200K |
|
|
CBI
1461
DELISTED
Chicago Bridge & Iron Nv
CBI
| $2.42M | 0.01% |
122,535
+22,242
| +22% | +$516K |
|
|
TAHO
1462
DELISTED
Tahoe Resources Inc
TAHO
| $2.41M | 0.01% |
279,952
-8,432
| -3% | -$73.5K |
|
|
CPLA
1463
DELISTED
Capella Education Company
CPLA
| $2.4M | 0.01% |
28,082
-332
| -1% | -$29.5K |
|
|
TBI
1464
Trueblue
TBI
$227M
| $2.4M | 0.01% |
90,675
+1,338
| +1% | +$35.7K |
|
|
BUFF
1465
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.4M | 0.01% |
105,021
+37,021
| +54% | +$876K |
|
1466
AdvanSix
ASIX
$542M
| $2.39M | 0.01% |
76,438
+23,167
| +43% | +$660K |
|
|
RP
1467
DELISTED
RealPage, Inc.
RP
| $2.39M | 0.01% |
66,413
+3,964
| +6% | +$142K |
|
|
EGOV
1468
DELISTED
NIC Inc
EGOV
| $2.39M | 0.01% |
125,982
-852
| -0.7% | -$17.4K |
|
1469
Invesco Mortgage Capital
IVR
$759M
| $2.38M | 0.01% |
14,266
-194
| -1% | -$31.4K |
|
1470
Agios Pharmaceuticals
AGIO
$2.08B
| $2.38M | 0.01% |
46,282
+9,374
| +25% | +$479K |
|
1471
Asbury Automotive
ABG
$4.62B
| $2.38M | 0.01% |
42,090
-3,372
| -7% | -$194K |
|
1472
Designer Brands
DBI
$315M
| $2.38M | 0.01% |
134,340
-6,263
| -4% | -$117K |
|
|
MNTA
1473
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.37M | 0.01% |
140,215
+11,128
| +9% | +$169K |
|
1474
Hilton Grand Vacations
HGV
$4.04B
| $2.37M | 0.01% |
65,632
+7,095
| +12% | +$245K |
|
1475
E.W. Scripps
SSP
$270M
| $2.35M | 0.01% |
132,206
-1,414
| -1% | -$27.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
- RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
- RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
- RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
- RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
- RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.
Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.